JELENA OZEGOVIC: Open Payments
NPI 1346743077 · DYER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,677 in 225 payments from 20 companies in 2025. Trend: 2023 $3,072 · 2024 $3,723 · 2025 $3,677
Food & beverage: $3,487Education: $190
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $445 |
| ABBVIE INC. | 44 | $442 |
| Janssen Biotech, Inc. | 14 | $362 |
| Incyte Corporation | 14 | $345 |
| Galderma Laboratories, L.P. | 17 | $275 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 21 | $273 |
| Arcutis Biotherapeutics, Inc. | 24 | $206 |
| Amgen Inc. | 7 | $203 |
| Novartis Pharmaceuticals Corporation | 11 | $199 |
| Regeneron Healthcare Solutions, Inc. | 5 | $195 |
Products named: Bimzelx, TREMFYA, SKYRIZI, OPZELURA, NEMLUVIO, DUPIXENT, Zoryve, OTEZLA.
Industry payments across IN — which companies pay providers there.
